Other languages Qlucore AB

Equities

QCORE

SE0016829824

Market Closed - Nasdaq Stockholm Other stock markets 10:21:49 2024-05-03 am EDT			5-day change	1st Jan Change
7.85 ^SEK	0.00%		-3.09%	+2.61%

Apr. 08	Qlucore Announces the Launch of the Qlucore Omics Explorer Cloud Version	CI
Feb. 28	Qlucore AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Qlucore Announces the Launch of the Qlucore Omics Explorer Cloud Version	Apr. 08
Qlucore AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	Feb. 28
Qlucore Diagnostics for Pediatric Leukemia Takes A Significant Step Closer to Ce Marking	Jan. 30
Sahlgrenska Hospital Invests in Precision Diagnostics with Qlucore AB Insights	Jan. 16
Boehringer Ingelheim Signs Two-Year Agreement with Qlucore	Jan. 11
Qlucore Announces Swedish Innovation Evaluated for Clinical Diagnosis of Pediatric Leukemia	Dec. 13
Qlucore AB Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023	Nov. 28
Qlucore AB Appoints Lars Höckenström as A Member of the Board of Directors	23-09-07
Qlucore AB Reports Earnings Results for the First Quarter Ended July 31, 2023	23-08-30
Qlucore AB Reports Earnings Results for the Fourth Quarter Ended April 30, 2023	23-05-31
Qlucore AB Reports Earnings Results for the Full Year Ended April 30, 2023	23-05-31
Qlucore Launches Qlucore Omics Explorer Version 3.9	23-04-26
Qlucore AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2023	23-02-28
Qlucore AB Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2022	22-11-28
Qlucore Software Used in New Project to Prevent Cardiovascular Diseases	22-11-17
Qlucore Receives Patent in Europe	22-09-26
Qlucore Ab Reports Earnings Results for the First Quarter Ended July 31, 2022	22-08-30
Qlucore Expands Its Leukemia Diagnostics Solution	22-08-26
Qlucore Ab Reports Earnings Results for the Full Year Ended April 30, 2022	22-06-08
Qlucore Announces New Collaboration in the Field of Precision Diagnostics to Develop Solutions for Improved Clinical Diagnostics of Bladder Cancer	22-05-23

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Qlucore AB

Equities

QCORE

SE0016829824

Other languages

Filters